Proton pump inhibitors (PPIs) have been increasingly used over the last decades and there
are concerns about overuse and the numerous reported side-effects. It is uncertain whether …

Proton pump inhibitors have an excellent safety profile and have become one of the most
commonly prescribed class of drugs in primary and specialty care. Long-term, sometimes …

The proton pump inhibitors (PPIs) as a class are remarkably safe and effective for persons
with peptic ulcer disorders. Serious adverse events are extremely rare for PPIs, with case …

OBJECTIVES: To use a large pathology database (Caris Diagnostics) to analyze the
frequency and associations of gastric polyps in a nationwide US population. METHODS: A …

Background Gastric polyps are important as some have malignant potential. If such polyps
are left untreated, gastric cancer may result. The malignant potential depends on the …

Background It is controversial whether proton pump inhibitor use leads to fundic gland polyp
development. Aim To determine whether fundic gland polyp development is due to proton …

4% of patients who undergo gastric biopsy have gastric polyps. These lesions may be true
epithelial polyps, heterotopias, lymphoid tissue, or stromal lesions. Hyperplastic polyps …

More than 15 years after the launch of omeprazole in 1988, proton‐pump inhibitors remain
central to the management of acid‐suppression disorders and are unchallenged with regard …

Drug-induced injury of the gastrointestinal (GI) tract is increasingly common but generally
under-recognized. Although there is an overwhelming number of drugs that are associated …

Proton pump inhibitors (PPIs) are used worldwide to treat of acid-related disorders such as
peptic ulcer and gastroesophageal reflux disease and to prevent gastroduodenal injuries …